4//SEC Filing
Broadfoot Jill Marie 4
Accession 0001209191-23-011275
CIK 0001339970other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:04 PM ET
Size
5.6 KB
Accession
0001209191-23-011275
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Broadfoot Jill Marie
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-16+84,023→ 84,023 totalExercise: $2.19Exp: 2033-02-16→ Common Stock (84,023 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 16, 2023, such that this option will be fully exercisable on February 16, 2027. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001305178
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:04 PM ET
- Size
- 5.6 KB